Jonathan M. Rigby
Signal active
President & CEO
Contact Information
Social
Primary Organization
Revolo Biotherapeutics
Founded
2011
Employees
1-10
Industry
Biotechnology, Life Science, Health Care
Bio
Jonathan has 23+ years commercial and senior leadership experience in the pharmaceutical, medical device and drug delivery industry, including Merck, Bristol Myers Squibb and Profile Therapeutics (Phillips).
In 2006, he Co-Founded Zogenix, Inc. a CNS Specialty Pharma Co with Drug Delivery Technology that raised over $250 Million in venture capital, developed a drug delivery enabled product from the pre-IND phase through to US launch followed by an IPO in 2010 (NASDAQ, ZGNX).
Jonathan has signed numerous licensing and M&A deals in the field of Drug Delivery resulting in a number of development stage products, a launched product in the EU for migraine therapy and a worldwide launched product for the treatment of Pulmonary Arterial Hypertension.
Location
New Orleans, Louisiana, United States, North America
Jobs history
4
Oncolytics Biotech
Member Board of Directors, Chairman Governance Committee
2022 - Current
Zogenix
Co Founder and VP Business Development
2006 - 2010
Sernova
Chairman and CEO
2024 - Current
Revolo Biotherapeutics
President & CEO
2020 - Current
Educations
1
N/A
Profile Resume
Jonathan M. Rigby is the President & CEO at Revolo Biotherapeutics, based in United States, North America. With a background in Biotechnology, Jonathan M. Rigby has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.